Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC

28 Julai 2026, 17:32:09
Hyperthyroidism
Hyperthyroidism is a condition in which the thyroid gland produces excessive amounts of thyroid hormones, resulting in increased metabolic activity. The most common causes include Graves' disease, toxic multinodular goitre, thyroiditis, and excessive iodine intake. Early diagnosis and appropriate management are important to prevent complications such as cardiac arrhythmias, osteoporosis, and thyroid storm.
Pathophysiology
Hyperthyroidism results from excessive synthesis and secretion of thyroid hormones (triiodothyronine [T3] and thyroxine [T4]), leading to increased basal metabolic rate and enhanced sympathetic nervous system activity. The underlying mechanism depends on the cause, including autoimmune stimulation of the thyroid gland, autonomous hormone production, inflammatory release of stored hormones, or excess iodine exposure.
Risk factors
Female sex
Family history of thyroid disease
Autoimmune disorders
Previous thyroid disease
Excessive iodine intake
Thyroiditis
Multinodular goitre
Thyroid nodules
Postpartum period
Smoking (especially in Graves' ophthalmopathy)
Diagnostic criteria
Hyperthyroidism should be suspected in patients presenting with:
Tremors
Excessive sweating
Smooth, velvety skin
Fine hair
Rapid heart rate
Enlarged thyroid gland
Frequent bowel movements
Investigations
Serum thyroid-stimulating hormone (TSH)
Free thyroxine (Free T4)
Baseline complete blood count, including differential white blood cell count
Liver function tests (bilirubin and transaminases)
Differential white blood cell count during febrile illness or onset of pharyngitis in patients receiving antithyroid medication (routine monitoring is not recommended)
Thyroid uptake scan when thyrotoxicosis is confirmed and the underlying cause is uncertain
Management
Management depends on the underlying cause of hyperthyroidism.
Non-pharmacological management
Provide patient education regarding the disease and treatment options.
Advise adequate nutrition and hydration.
Encourage smoking cessation, particularly in patients with thyroid eye disease.
Arrange regular clinical follow-up and thyroid function monitoring.
Pharmacological management
Treatment should be selected according to the underlying cause of hyperthyroidism.
Beta-blockers may be used for symptomatic relief of adrenergic symptoms such as palpitations and tremor.
Antithyroid medicines, radioactive iodine therapy, or surgery are selected according to the specific cause and individual patient factors.
Monitoring
Repeat TSH and Free T4 to assess treatment response.
Monitor for adverse effects of antithyroid medicines, particularly agranulocytosis and hepatotoxicity.
Advise patients receiving antithyroid medicines to seek urgent medical attention if they develop fever or sore throat.
Continue regular clinical assessment until euthyroidism is achieved.
Complications
Atrial fibrillation
Heart failure
Osteoporosis
Thyroid storm
Weight loss and malnutrition
Ophthalmopathy (in Graves' disease)
Prognosis
The prognosis depends on the underlying cause and timely initiation of treatment. Most patients achieve good symptom control with appropriate therapy and regular follow-up. Delayed diagnosis or untreated disease increases the risk of cardiovascular complications, osteoporosis, and thyroid storm.
Imeandikwa:
25 Novemba 2020, 15:27:45
Rejea za mada hii:
Ministry of Health, United Republic of Tanzania. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 2024 ed. Dodoma: Ministry of Health; 2021.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2022 European Thyroid Association Clinical Practice Guideline for the management of Graves' hyperthyroidism. Eur Thyroid J. 2022;11(1):e210067.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-421.
Jameson JL, Mandel SJ, Weetman AP. Disorders of the thyroid gland. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 22nd ed. New York: McGraw-Hill; 2022.
World Health Organization. Package of essential noncommunicable disease interventions (WHO PEN) for primary health care. Geneva: World Health Organization; 2020.
Disclaimer: The information provided on this platform is for educational and informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Clinical recommendations are primarily based on the Tanzania Standard Treatment Guidelines and National Essential Medicines List (STG & NEMLIT), Seventh Edition, 2021, unless otherwise stated.
